GLYPRESSIN

This brand name is authorized in Brazil, Ecuador, Estonia, Spain, Finland, Hong Kong, Croatia, Ireland, Israel, Lithuania, Netherlands, New Zealand, Poland, Romania, Singapore, Tunisia, Turkey, United Kingdom, South Africa

Active ingredients

The drug GLYPRESSIN contains one active pharmaceutical ingredient (API):

1 Terlipressin
UNII 4U092XZF0K - TERLIPRESSIN ACETATE

Terlipressin inhibits portal hypertension with simultaneous reduction of blood circulation in portal vessels. Terlipressin contracts smooth oesophageal muscle with consecutive compression of oesophageal varices.

Read about Terlipressin

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC code Group title Classification
H01BA04 Terlipressin H Systemic hormonal preparations, excl. Sex hormones and insulins → H01 Pituitary and hypothalamic hormones and analogues → H01B Posterior pituitary lobe hormones → H01BA Vasopressin and analogues
Discover more medicines within H01BA04

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country Identification scheme Identifier(s)
Country: BR Câmara de Regulação do Mercado de Medicamentos Identifier(s): 521400302157318, 521418020006303
Country: EC Agencia Nacional de Regulación, Control y Vigilancia Sanitaria Identifier(s): 46-MEE-0114
Country: EE Ravimiamet Identifier(s): 1186095, 1480441
Country: ES Centro de información online de medicamentos de la AEMPS Identifier(s): 61412, 72359
Country: FI Lääkealan turvallisuus- ja kehittämiskeskus Identifier(s): 031942, 088230
Country: GB Medicines & Healthcare Products Regulatory Agency Identifier(s): 180249, 48250
Country: HK Department of Health Drug Office Identifier(s): 36916, 61791
Country: HR Agencija za lijekove i medicinske proizvode Identifier(s): HR-H-413434003
Country: IL מִשְׂרַד הַבְּרִיאוּת Identifier(s): 6871
Country: LT Valstybinė vaistų kontrolės tarnyba Identifier(s): 1019805, 1054751
Country: NL Z-Index G-Standaard Identifier(s): 13487337
Country: NL Z-Index G-Standaard, PRK Identifier(s): 90301
Country: NZ Medicines and Medical Devices Safety Authority Identifier(s): 14932
Country: PL Rejestru Produktów Leczniczych Identifier(s): 100147770, 100238684
Country: RO Agenția Națională a Medicamentului și a Dispozitivelor Medicale Identifier(s): W43555001, W67158001
Country: SG Health Sciences Authority Identifier(s): 07783P, 14244P
Country: TN Direction de la Pharmacie et du Médicament Identifier(s): 12883011H
Country: TR İlaç ve Tıbbi Cihaz Kurumu Identifier(s): 8697621750364, 8697621790087
Country: ZA Health Products Regulatory Authority Identifier(s): 43/21.13/0829

© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.